Business Context and Reporting Period
Company: Humana Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2003
Business Overview: Humana is a major health benefits company offering coordinated health insurance coverage through traditional and Internet-based plans. The company operates two primary segments: Commercial (employer groups and individuals) and Government (Medicare+Choice, Medicaid, and TRICARE). As of September 30, 2003, the company served approximately 6.6 million medical members and 1.6 million specialty members.
Key Financial Metrics
| Metric (Nine Months Ended Sept 30, 2003) | Value (in thousands) |
|---|---|
| Total Revenues | $9,073,439 |
| Net Income | $162,625 |
| Diluted Earnings Per Share | $1.01 |
| Operating Cash Flow | $122,920 |
| Medical Expense Ratio (MER) | 83.7% |
| SG&A Expense Ratio | 15.3% |
| Total Assets | $4,749,724 |
| Total Liabilities | $2,990,600 |
| Long-Term Debt | $644,440 |
| Cash and Cash Equivalents | $635,837 |
Material Changes vs. Prior Period
- Revenue Growth: Total revenues increased 7.9% to $9.07 billion for the nine months ended September 30, 2003, compared to $8.41 billion in the prior year period. Premium revenues rose 7.8% to $8.77 billion.
- Profitability: Net income increased 12.6% to $162.6 million from $144.5 million in the prior year. Diluted EPS rose to $1.01 from $0.86.
- Segment Performance:
- Commercial Segment: Income before taxes surged to $106.9 million from $45.5 million, driven by a 13.1% increase in premium revenues and improved medical expense ratios (82.7% vs. 83.4%).
- Government Segment: Income before taxes declined to $138.1 million from $166.9 million. This was primarily due to a higher Medical Expense Ratio (85.0% vs. 84.1%) in the TRICARE business caused by increased utilization related to military conflicts.
- Debt Structure: Long-term debt increased significantly to $644.4 million from $340.0 million, following the issuance of $300 million in 6.30% senior notes due 2018 in August 2003. Short-term debt was fully repaid.
- Cash Flow: Operating cash flow improved dramatically to a positive $122.9 million from a negative $101.3 million in the prior year, largely due to improved earnings and collections of TRICARE receivables.
Guidance, Outlook, and Risks
Management Commentary and Outlook
- Commercial Growth: Management expects Commercial fully insured and ASO medical membership to grow 2% to 3% for the full year 2003. Fully insured per member premiums are expected to grow 12% to 14%.
- Government Segment: Medicare+Choice membership is expected to decline to between 325,000 and 330,000 by year-end, with per member premiums increasing 4% to 6%.
- Cost Ratios: The company expects the Commercial SG&A ratio to range from 16.5% to 16.9% and the Government SG&A ratio from 12.8% to 13.2% for 2003.
- Capital Expenditures: Total capital expenditures for 2003 are projected to be approximately $95 million, focused on technology initiatives.
Risks and Contingencies
- Restructuring and Asset Charges: The company recorded non-cash charges of approximately $30.8 million in the first nine months of 2003 related to the writedown and accelerated depreciation of long-lived assets (buildings and software) associated with the consolidation of customer service centers.
- Government Contract Uncertainty:
- TRICARE: Humana was awarded the South Region contract but faces protests from unsuccessful bidders. The transition to new regions is delayed until mid-to-late 2004. Humana was not awarded the TRICARE Retail Pharmacy contract and has filed a protest.
- Medicare+Choice: Legislative proposals regarding prescription drug benefits and private plan options remain uncertain, posing risks to reimbursement rates and program participation.
- Legal Proceedings:
- Securities Litigation: A settlement of $10.2 million has been reached regarding the PCA securities litigation, pending court approval.
- Managed Care Litigation: Humana is a defendant in a consolidated class action lawsuit alleging improper claim payments and "downcoding." A trial is set for June 30, 2004.
- Antitrust Settlement: Humana entered a settlement regarding antitrust suits in Ohio and Kentucky, agreeing to increase future physician reimbursements by $45 million over three years ($20M in 2004, $15M in 2005, $10M in 2006).
- Regulatory Compliance: The company is subject to HIPAA regulations and various state/federal audits. Failure to comply or adverse audit results could lead to fines or loss of licensure.
Investor Verification Checklist
- TRICARE Contract Status: Verify the outcome of the protests regarding the South Region TRICARE contract and the Retail Pharmacy appeal, as these impact future government revenue stability.
- Medical Expense Ratios: Monitor the Government segment's MER, which rose to 85.0%, to ensure it does not erode profitability further due to utilization trends.
- Legal Settlements: Confirm the final court approval of the $10.2 million PCA securities settlement and the $45 million antitrust reimbursement agreement.
- Debt Servicing: Review the impact of the new $300 million senior notes on interest expense and liquidity, noting the use of interest rate swaps to hedge risk.
- Membership Trends: Track the decline in Medicare+Choice membership against the projected growth in Commercial membership to assess the overall portfolio mix.